Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

Genes Chromosomes and Cancer

Volumn 47, Issue 10, 2008, Pages 873-883

  Fejzo, Marlena Schoenberg ^a,c   Dering, Judy ^a   Ginther, Chuck ^a   Anderson, Lee ^a   Ramos, Lilian ^a   Walsh, Christine ^b   Karlan, Beth ^b   Slamon, Dennis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c 5535 MRL Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ADRM1 GENE; ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 20Q; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TPD54 GENE; ZNF217 GENE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; BLOTTING, NORTHERN; CHROMOSOMES, HUMAN, PAIR 20; CYSTADENOCARCINOMA, SEROUS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; RNA, NEOPLASM; SURVIVAL RATE; TIME FACTORS; TISSUE ARRAY ANALYSIS; TRANS-ACTIVATORS;

EID: 50249140088     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20592     Document Type: Article

References (24)

1. Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. 2006. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmaco 57:234-240.
2. Byrne JA, Balleine RL, Schoenberg Fejzo M, Mercieca J, Chiew YE, Livnat Y, St Heaps L, Peters GB, Byth K, Karlan BY, Slamon DJ, Harnett P, Defazio A. 2005. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. Int J Cancer 117:1049-1054.
3. Cherix N, Frocquet R, Charette SJ, Blanc C, Letourneur F, Cosson P. 2006. A Phg2-ADRM1 pathway participates in the nutrient-controlled developmental response in Dictyostelium. Mol Biol Cell 17:4982-4987.
4. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li WB, Gray JW. 1998. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 95:8703-8708.
5. 2 from contingency tables, and the calculation of P. J Roy Stat Soc 85:87-94.
6. Hamazaki J, Iemura S, Natsume T, Yashiroda H, Tanaka K, Murata S. 2006. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S -proteasomes. EMBO J 25:4524-4536.
7. Israeli O, Goldring-Aviram A, Rienstein S, Ben-Baruch G, Korach J, Goldman B, Friedman E. 2005. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet 160:35-42.
8. Kim SW, Kim JW, Kim YT, Kim JH, Kim S, Yoon BS, Nam EJ, Kim HY. 2007. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer. 46:1-9.
9. Lamerant N, Kieda C. 2005. Adhesion properties of adhesion-regulating molecule 1 ptotein on endothelial cells. FEBS J 272:1833-1844.
10. Lee JM. 2003. The role of protein elongation factor cEF1A2 in ovarian cancer. Reprod Biol Endocrinol 1:69.
11. Li P, Maines-Bandiera S, Kuo WL, Gnan Y, Sun Y, Hills M, Huang G, Collins CC, Leung PC, Gray JW, Auersperg N. 2007. Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression. Int J Cancer 120:1863-1873.
12. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grützmann R. 2004. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6:744-750.
13. Qiu XB, Ouyang SY, Li CJ, Miao S, Wang L, Goldberg AL. 2006. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25:5742-5753.
14. Schmandt RE, Bennett M, Clifford S, Thornton A, Jiang F, Broaddus RR, Sun CC, Lu KH, Sood AK, Gershenson DM. 2006. The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. Cancer Biol Ther 5:1136-1141.
15. Schoenberg Fejzo M, Slamon DJ. 2001. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol 159:1645-1650.
16. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC, Jr, James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI. 2001. Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res 61:5895-5904.
17. Simins AB, Weighardt H, Weidner KM, Weidle UH, Holzmann B. 1999. Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells. Clin Exp Metastasis 17:641-648.
18. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR. 1997. Comparative genomic hybridization detects frequent overreprescntation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20:320-328.
19. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ. 2000. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 6:1833-1839.
20. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J, Rencs J. 2004. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 61:2405-2417.
21. Watanabe T, Imoto I, Katahira T, Hirasawa A, Ishiwata I, Emi M, Takayama M, Sato A, Inazawa J. 2002. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Jpn J Cancer Res 93:1114-1122.
22. Wolf NG, Abdul-Karim FW, Farver C, Schröck E, du Manoir S, Schwartz S. 1999. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybtidization. Genes Chromosomes Cancer 25:307-315.
23. Yang JM. 2007. Emerging roles of deubiquitinating enzymes in human cancer. Acta Pharmacol Sin 28:1325-1330.
24. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. 1998. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20:104-106.